Lumacaftor
鲁玛卡托
Report date: 2024/05/17 10:16:14
NME
Base Information
Drug NameLumacaftor
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[17]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals IncorporatedCystic Fibrosis Foundation Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesQanatpharma Canada LtdCystic Fibrosis Foundation TherapeuticsVertex Pharmaceuticals Incorporated +[4]
Inactive CompaniesBayer AG
Active Indications
Inactive Indications